ArticleJournal of molecular medicine (Berlin, Germany)2026

Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy.

Maria Jordan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.